Related Experiment Video

Updated: Aug 9, 2026

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

Lamin A/C and cardiac diseases

Nicolas Sylvius1, Frédérique Tesson

  • 1University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Current Opinion in Cardiology
|April 8, 2006
PubMed

Insights

Mutations in the lamin A/C gene (LMNA) are linked to dilated cardiomyopathy and heart failure. Early diagnosis is challenging, but understanding nuclear architecture and transcription roles is key for cardiac disease management.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Nuclear Architecture

Background:

  • Lamin A/C, encoded by the LMNA gene, plays a critical role in nuclear structure and function.
  • LMNA mutations are implicated in a spectrum of diseases affecting multiple tissues, including the heart, skeletal muscle, and adipose tissue.

Purpose of the Study:

  • To review recent significant findings on the role of lamin A/C in cardiac diseases.
  • To elucidate the connection between LMNA mutations and the pathogenesis of dilated cardiomyopathy.

Main Methods:

  • Review of current literature on LMNA mutations and cardiac phenotypes.
  • Analysis of data from cellular and animal models investigating lamin A/C function.
  • Examination of findings from patient biopsies and fibroblasts.

Main Results:

  • LMNA mutations are a prevalent cause of dilated cardiomyopathy, associated with high risks of arrhythmias, sudden death, and heart failure.
  • Lamins A and C are crucial for maintaining nuclear architecture and regulating transcription, though specific disease-related abnormalities are not consistently observed in patient tissues.
  • Early diagnosis of LMNA-related cardiac disease remains difficult.

Conclusions:

  • The cardiac manifestations of LMNA mutations are increasingly understood, but the underlying molecular mechanisms driving tissue-specific phenotypes require further investigation.
  • Systematic screening for LMNA mutations and consideration of cardioverter-defibrillator implantation are recommended for patients with cardiac symptoms.
Abstract

More Related Videos

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture07:44

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture

Published on: March 3, 2023

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Laminins are the Adhesive Proteins of Basal Lamina00:55

Laminins are the Adhesive Proteins of Basal Lamina

Laminins are heterotrimeric proteins with high molecular mass found in the extracellular matrix. Each laminin molecule is composed of three chains, viz. alpha, beta, and gamma, coded by five, four, and three paralogous genes, respectively. Laminins are categories based on the compositions of the three chains.
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...